CA2881614A1 - Dual panel photodynamic therapy lamp - Google Patents
Dual panel photodynamic therapy lamp Download PDFInfo
- Publication number
- CA2881614A1 CA2881614A1 CA2881614A CA2881614A CA2881614A1 CA 2881614 A1 CA2881614 A1 CA 2881614A1 CA 2881614 A CA2881614 A CA 2881614A CA 2881614 A CA2881614 A CA 2881614A CA 2881614 A1 CA2881614 A1 CA 2881614A1
- Authority
- CA
- Canada
- Prior art keywords
- lamp
- leds
- treatment
- degrees
- modules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002428 photodynamic therapy Methods 0.000 title claims abstract description 147
- 230000009977 dual effect Effects 0.000 title description 5
- 238000011282 treatment Methods 0.000 claims description 193
- 238000005286 illumination Methods 0.000 claims description 67
- 238000001816 cooling Methods 0.000 claims description 42
- 230000003287 optical effect Effects 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 6
- 239000003504 photosensitizing agent Substances 0.000 description 89
- 238000000034 method Methods 0.000 description 78
- 239000002243 precursor Substances 0.000 description 55
- 206010000496 acne Diseases 0.000 description 46
- 229960002749 aminolevulinic acid Drugs 0.000 description 45
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical class NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 43
- 208000002874 Acne Vulgaris Diseases 0.000 description 43
- 150000003839 salts Chemical class 0.000 description 40
- 210000003128 head Anatomy 0.000 description 33
- 210000003491 skin Anatomy 0.000 description 33
- -1 for example Chemical class 0.000 description 26
- 239000000203 mixture Substances 0.000 description 26
- 230000003902 lesion Effects 0.000 description 22
- 208000009621 actinic keratosis Diseases 0.000 description 13
- 210000004027 cell Anatomy 0.000 description 13
- 239000002537 cosmetic Substances 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 239000006071 cream Substances 0.000 description 12
- 230000002757 inflammatory effect Effects 0.000 description 12
- 201000010099 disease Diseases 0.000 description 10
- 238000011200 topical administration Methods 0.000 description 10
- 238000011534 incubation Methods 0.000 description 9
- 230000001681 protective effect Effects 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 6
- 239000003570 air Substances 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 6
- 210000001061 forehead Anatomy 0.000 description 6
- 239000000902 placebo Substances 0.000 description 6
- 229940068196 placebo Drugs 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 230000001815 facial effect Effects 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 238000003491 array Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000001126 phototherapy Methods 0.000 description 4
- 238000002203 pretreatment Methods 0.000 description 4
- 206010051246 Photodermatosis Diseases 0.000 description 3
- 206010039509 Scab Diseases 0.000 description 3
- 208000000453 Skin Neoplasms Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 231100000321 erythema Toxicity 0.000 description 3
- 210000000887 face Anatomy 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000013178 mathematical model Methods 0.000 description 3
- 150000004702 methyl esters Chemical class 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 208000006994 Precancerous Conditions Diseases 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 2
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 2
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000004886 head movement Effects 0.000 description 2
- BTXNYTINYBABQR-UHFFFAOYSA-N hypericin Chemical compound C12=C(O)C=C(O)C(C(C=3C(O)=CC(C)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 BTXNYTINYBABQR-UHFFFAOYSA-N 0.000 description 2
- 229940005608 hypericin Drugs 0.000 description 2
- PHOKTTKFQUYZPI-UHFFFAOYSA-N hypericin Natural products Cc1cc(O)c2c3C(=O)C(=Cc4c(O)c5c(O)cc(O)c6c7C(=O)C(=Cc8c(C)c1c2c(c78)c(c34)c56)O)O PHOKTTKFQUYZPI-UHFFFAOYSA-N 0.000 description 2
- 238000011221 initial treatment Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000011369 optimal treatment Methods 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 150000004032 porphyrins Chemical class 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- SSKVDVBQSWQEGJ-UHFFFAOYSA-N pseudohypericin Natural products C12=C(O)C=C(O)C(C(C=3C(O)=CC(O)=C4C=33)=O)=C2C3=C2C3=C4C(C)=CC(O)=C3C(=O)C3=C(O)C=C(O)C1=C32 SSKVDVBQSWQEGJ-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OYINILBBZAQBEV-UWJYYQICSA-N (17s,18s)-18-(2-carboxyethyl)-20-(carboxymethyl)-12-ethenyl-7-ethyl-3,8,13,17-tetramethyl-17,18,22,23-tetrahydroporphyrin-2-carboxylic acid Chemical compound N1C2=C(C)C(C=C)=C1C=C(N1)C(C)=C(CC)C1=CC(C(C)=C1C(O)=O)=NC1=C(CC(O)=O)C([C@@H](CCC(O)=O)[C@@H]1C)=NC1=C2 OYINILBBZAQBEV-UWJYYQICSA-N 0.000 description 1
- ILBBNQMSDGAAPF-UHFFFAOYSA-N 1-(6-hydroxy-6-methylcyclohexa-2,4-dien-1-yl)propan-1-one Chemical compound CCC(=O)C1C=CC=CC1(C)O ILBBNQMSDGAAPF-UHFFFAOYSA-N 0.000 description 1
- MHIITNFQDPFSES-UHFFFAOYSA-N 25,26,27,28-tetrazahexacyclo[16.6.1.13,6.18,11.113,16.019,24]octacosa-1(25),2,4,6,8(27),9,11,13,15,17,19,21,23-tridecaene Chemical class N1C(C=C2C3=CC=CC=C3C(C=C3NC(=C4)C=C3)=N2)=CC=C1C=C1C=CC4=N1 MHIITNFQDPFSES-UHFFFAOYSA-N 0.000 description 1
- KFKRXESVMDBTNQ-UHFFFAOYSA-N 3-[18-(2-carboxylatoethyl)-8,13-bis(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-21,24-diium-2-yl]propanoate Chemical class N1C2=C(C)C(C(C)O)=C1C=C(N1)C(C)=C(C(O)C)C1=CC(C(C)=C1CCC(O)=O)=NC1=CC(C(CCC(O)=O)=C1C)=NC1=C2 KFKRXESVMDBTNQ-UHFFFAOYSA-N 0.000 description 1
- 206010000501 Acne conglobata Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000013165 Bowen disease Diseases 0.000 description 1
- 208000019337 Bowen disease of the skin Diseases 0.000 description 1
- VSEIDZLLWQQJGK-CHOZPQDDSA-N CCC1=C(C)C2=N\C\1=C/C1=C(C)C(C(O)=O)=C(N1)\C(CC(=O)N[C@@H](CC(O)=O)C(O)=O)=C1/N=C(/C=C3\N/C(=C\2)C(C=C)=C3C)[C@@H](C)[C@@H]1CCC(O)=O Chemical compound CCC1=C(C)C2=N\C\1=C/C1=C(C)C(C(O)=O)=C(N1)\C(CC(=O)N[C@@H](CC(O)=O)C(O)=O)=C1/N=C(/C=C3\N/C(=C\2)C(C=C)=C3C)[C@@H](C)[C@@H]1CCC(O)=O VSEIDZLLWQQJGK-CHOZPQDDSA-N 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 241001464974 Cutibacterium avidum Species 0.000 description 1
- 241001464975 Cutibacterium granulosum Species 0.000 description 1
- 241001635598 Enicostema Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241001459566 Papulosa Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 206010066901 Treatment failure Diseases 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- KMWBBMXGHHLDKL-UHFFFAOYSA-N [AlH3].[Si] Chemical compound [AlH3].[Si] KMWBBMXGHHLDKL-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004036 bacteriochlorins Chemical class 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000004035 chlorins Chemical class 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 208000037765 diseases and disorders Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000017525 heat dissipation Effects 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100001079 no serious adverse effect Toxicity 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036555 skin type Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229950010924 talaporfin Drugs 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 229960002197 temoporfin Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- ZQFGRJWRSLZCSQ-ZSFNYQMMSA-N verteporfin Chemical compound C=1C([C@@]2([C@H](C(=O)OC)C(=CC=C22)C(=O)OC)C)=NC2=CC(C(=C2C=C)C)=NC2=CC(C(=C2CCC(O)=O)C)=NC2=CC2=NC=1C(C)=C2CCC(=O)OC ZQFGRJWRSLZCSQ-ZSFNYQMMSA-N 0.000 description 1
- 229960003895 verteporfin Drugs 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 210000000216 zygoma Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N2005/002—Cooling systems
- A61N2005/007—Cooling systems for cooling the patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0626—Monitoring, verifying, controlling systems and methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0632—Constructional aspects of the apparatus
- A61N2005/0633—Arrangements for lifting or hinging the frame which supports the light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0642—Irradiating part of the body at a certain distance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
- A61N2005/0652—Arrays of diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0662—Visible light
- A61N2005/0663—Coloured light
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12182486 | 2012-08-30 | ||
| EP12182486.6 | 2012-08-30 | ||
| PCT/EP2013/067982 WO2014033254A1 (en) | 2012-08-30 | 2013-08-30 | Dual panel photodynamic therapy lamp |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2881614A1 true CA2881614A1 (en) | 2014-03-06 |
Family
ID=46888911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2881614A Abandoned CA2881614A1 (en) | 2012-08-30 | 2013-08-30 | Dual panel photodynamic therapy lamp |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US20140067024A1 (enExample) |
| EP (1) | EP2890458B1 (enExample) |
| JP (1) | JP2015528338A (enExample) |
| BR (1) | BR112015004114A2 (enExample) |
| CA (1) | CA2881614A1 (enExample) |
| EA (1) | EA201590362A1 (enExample) |
| ES (1) | ES2685326T3 (enExample) |
| WO (1) | WO2014033254A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110393862A (zh) * | 2019-08-28 | 2019-11-01 | 武汉优瑞科技有限公司 | 一种用于耳朵治疗的光子治疗仪 |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2881439C (en) * | 2012-08-10 | 2017-08-29 | Dusa Pharmaceuticals, Inc. | Method for the treatment of acne |
| BR112016014073A2 (pt) | 2013-12-20 | 2017-08-08 | Galderma Res & Dev | Tratamento fotodinâmico de pulso de pele fotodanificada |
| PL410162A1 (pl) | 2014-11-17 | 2016-05-23 | Wojskowa Akademia Techniczna | Oświetlacz LED z wyjściem światłowodowym |
| JP6516219B2 (ja) * | 2015-06-24 | 2019-05-22 | 公立大学法人名古屋市立大学 | 光線力学的治療用光照射装置 |
| EP3328491A4 (en) | 2015-07-28 | 2019-05-01 | PhotonMD, Inc. | SYSTEMS AND METHOD FOR THE LIGHT THERAPEUTIC MODULATION OF STICK OXIDE |
| US12109429B2 (en) | 2015-07-28 | 2024-10-08 | Know Bio, Llc | Phototherapeutic light for treatment of pathogens |
| EP3851161A1 (en) | 2015-10-15 | 2021-07-21 | DUSA Pharmaceuticals, Inc. | Adjustable illuminator for photodynamic therapy and diagnosis |
| US10603508B2 (en) * | 2015-10-15 | 2020-03-31 | Dusa Pharmaceuticals, Inc. | Adjustable illuminators and methods for photodynamic therapy and diagnosis |
| FI20155784A7 (fi) | 2015-11-02 | 2017-05-03 | Cryotech Nordic Oue | Automatisoitu järjestelmä laser-avusteiseen dermatologiseen hoitoon ja ohjausmenetelmä |
| GB201522398D0 (en) * | 2015-12-18 | 2016-02-03 | Photocure As | Device for photodynamic therapy |
| CN106237534B (zh) * | 2016-08-29 | 2018-06-29 | 武汉亚格光电技术股份有限公司 | 智能型鲜红斑痣光动力治疗仪系统 |
| WO2018117787A1 (es) * | 2016-12-19 | 2018-06-28 | Castro Baldenebro Brayan Gamaniel | Sistema de aplicación de luz focalizada para tratamiento de afecciones de la piel causada por acné |
| CA3057840A1 (en) * | 2017-04-14 | 2018-10-18 | Dusa Pharmaceuticals, Inc. | Adjustable illuminators and methods for photodynamic therapy and diagnosis |
| US12233279B2 (en) | 2017-05-30 | 2025-02-25 | Icahn School Of Medicine At Mount Sinai | Device for photo-therapy and use thereof |
| US11273320B2 (en) | 2017-05-30 | 2022-03-15 | Tcellerate Llc | Device for photo-therapy of Grover's disease and use thereof |
| US10155122B1 (en) * | 2017-05-30 | 2018-12-18 | William Woodburn | Device for photo-therapy of grover's disease and use thereof |
| AU2018302103B2 (en) * | 2017-07-17 | 2024-03-07 | Sun Pharmaceutical Industries, Inc. | Photodynamic therapy method for skin disorders |
| CN108310674B (zh) * | 2017-12-21 | 2019-08-13 | 宁波大学 | 一种用于光动力治疗的光源 |
| US10357567B1 (en) | 2018-01-12 | 2019-07-23 | Dusa Pharmaceuticals, Inc. | Methods for photodynamic therapy |
| CN108543226B (zh) * | 2018-04-27 | 2020-01-07 | 王淑娟 | 一种可多角度实施治疗的骨伤恢复烤灯 |
| JP7336756B2 (ja) * | 2018-09-28 | 2023-09-01 | 公立大学法人名古屋市立大学 | 光線治療装置および光線治療装置の光出射方法 |
| US10478635B1 (en) | 2018-10-22 | 2019-11-19 | Joovv, Inc. | Photobiomodulation therapy systems and methods |
| US11458328B2 (en) | 2018-10-22 | 2022-10-04 | Joovv, Inc. | Photobiomodulation therapy device accessories |
| KR102100567B1 (ko) * | 2018-11-14 | 2020-04-13 | 최순철 | 피부관리기 |
| AU2020303417B2 (en) * | 2019-06-25 | 2025-08-28 | Sun Pharmaceutical Industries, Inc. | Methods for reducing pain during photodynamic therapy of actinic keratosis |
| US11986666B2 (en) | 2020-03-19 | 2024-05-21 | Know Bio, Llc | Illumination devices for inducing biological effects |
| US11147984B2 (en) | 2020-03-19 | 2021-10-19 | Know Bio, Llc | Illumination devices for inducing biological effects |
| US12447354B2 (en) | 2020-03-19 | 2025-10-21 | Know Bio, Llc | Illumination devices for inducing biological effects |
| US12011611B2 (en) | 2020-03-19 | 2024-06-18 | Know Bio, Llc | Illumination devices for inducing biological effects |
| JP7462242B2 (ja) * | 2020-06-19 | 2024-04-05 | パナソニックＩｐマネジメント株式会社 | 光照射型美容装置及び電子機器 |
| US11235169B1 (en) * | 2020-10-15 | 2022-02-01 | Biofrontera Pharma Gmbh | Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination device |
| US12347337B2 (en) | 2020-12-10 | 2025-07-01 | Know Bio, Llc | Enhanced testing and characterization techniques for phototherapeutic light treatments |
| CN112972904B (zh) * | 2021-02-22 | 2022-06-07 | 四川大学华西医院 | 一种模块化的led灯光动力治疗仪 |
| US12115384B2 (en) | 2021-03-15 | 2024-10-15 | Know Bio, Llc | Devices and methods for illuminating tissue to induce biological effects |
| US11654294B2 (en) | 2021-03-15 | 2023-05-23 | Know Bio, Llc | Intranasal illumination devices |
| ES2928172B2 (es) * | 2021-05-14 | 2023-04-26 | Univ Alcala Henares | Dispositivo luminoso con diodos led orientados |
| US20230043049A1 (en) * | 2021-08-09 | 2023-02-09 | Photonic Healing, LLC DBA Visum Light | Mobile configurable light therapy device |
| USD1073965S1 (en) * | 2021-08-10 | 2025-05-06 | Medmix Co., Ltd. | Medical LED skin enhancement apparatus |
| US20230181923A1 (en) * | 2021-12-09 | 2023-06-15 | Zerigo Health, Inc. | Apparatus and method for treating skin lesions |
| USD1010838S1 (en) * | 2022-01-26 | 2024-01-09 | Kernel Medical Equipment Co., Ltd | Photodynamic therapy device |
| JP2023109524A (ja) * | 2022-01-27 | 2023-08-08 | キヤノンメディカルシステムズ株式会社 | 光照射計画装置、光照射支援装置、医用情報処理システム及び医用情報処理方法 |
| USD1060697S1 (en) * | 2022-08-19 | 2025-02-04 | HOT Brands, LLC | Stand-up red light therapy device |
| KR102511380B1 (ko) | 2022-10-07 | 2023-03-17 | 주식회사 다람 | 남성 생식기 웨어러블 장치 |
| USD1052103S1 (en) * | 2022-10-18 | 2024-11-19 | Biofrontera Pharma Gmbh | Photodynamic therapy lamp head |
| USD1067446S1 (en) * | 2022-10-18 | 2025-03-18 | Biofrontera Pharma Gmbh | Photodynamic therapy lamp |
| EP4605072A1 (en) * | 2022-10-20 | 2025-08-27 | Biofrontera Pharma GmbH | Illumination device for photodynamic therapy, method for treating a skin disease and method for operating an illumination device |
| WO2025160272A1 (en) * | 2024-01-24 | 2025-07-31 | Biofrontera Inc. | Illumination device |
| USD1077259S1 (en) * | 2024-09-02 | 2025-05-27 | Chen Guo | Red light therapy device |
| USD1073918S1 (en) | 2024-12-03 | 2025-05-06 | Erchonia Corporation, Llc | Floor stand for phototherapy device |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4740707A (en) * | 1986-10-27 | 1988-04-26 | Allan Thaw | Portable tanning unit |
| US5420768A (en) | 1993-09-13 | 1995-05-30 | Kennedy; John | Portable led photocuring device |
| CZ291132B6 (cs) | 1995-03-10 | 2002-12-11 | Photocure Asa | Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem |
| US6712481B2 (en) | 1995-06-27 | 2004-03-30 | Solid State Opto Limited | Light emitting panel assemblies |
| NO972244L (no) | 1997-05-15 | 1998-11-16 | Photocure | Innretning for belysning av et avgrenset omrÕde |
| FR2777782B1 (fr) | 1998-04-22 | 2001-05-18 | Alexandre Marti | Solution pour la preparation d'une substance pharmaceutique pour le diagnostic et/ou le traitement de lesions tissulaires |
| US20060212025A1 (en) | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US6887260B1 (en) | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
| US6936044B2 (en) | 1998-11-30 | 2005-08-30 | Light Bioscience, Llc | Method and apparatus for the stimulation of hair growth |
| US6663659B2 (en) | 2000-01-13 | 2003-12-16 | Mcdaniel David H. | Method and apparatus for the photomodulation of living cells |
| US20040122492A1 (en) | 1999-07-07 | 2004-06-24 | Yoram Harth | Phototherapeutic treatment of skin conditions |
| US20020128695A1 (en) * | 1999-07-07 | 2002-09-12 | Yoram Harth | Apparatus and method for high energy photodynamic therapy of acne vulgaris and seborrhea |
| US20030216795A1 (en) | 1999-07-07 | 2003-11-20 | Yoram Harth | Apparatus and method for high energy photodynamic therapy of acne vulgaris, seborrhea and other skin disorders |
| GB2360459B (en) | 2000-03-23 | 2002-08-07 | Photo Therapeutics Ltd | Therapeutic light source and method |
| CA2444891A1 (en) | 2001-01-22 | 2002-08-15 | Eric Larsen | Photodynamic stimulation device and methods |
| GB0113899D0 (en) | 2001-06-07 | 2001-08-01 | Photocure Asa | Photodynamic therapy lamp |
| EP1312353A1 (en) | 2001-11-16 | 2003-05-21 | Ecole Polytechnique Federale De Lausanne (Epfl) | Method for hair removal |
| US20060293727A1 (en) | 2002-05-09 | 2006-12-28 | Greg Spooner | System and method for treating exposed tissue with light emitting diodes |
| US20080091250A1 (en) | 2002-09-26 | 2008-04-17 | Lumiport, Llc | Light therapy desk lamp |
| US6872220B2 (en) | 2003-01-16 | 2005-03-29 | Lumitex, Inc. | Infant phototherapy positioning system |
| GB0406917D0 (en) | 2004-03-26 | 2004-04-28 | Photocure Asa | Compounds |
| US7207694B1 (en) | 2004-08-20 | 2007-04-24 | Boyd Industries, Inc. | Light emitting diode operating and examination light system |
| GB0424833D0 (en) | 2004-11-10 | 2004-12-15 | Photocure Asa | Method |
| WO2006060905A1 (en) * | 2004-12-07 | 2006-06-15 | Elumen Lighting Networks Inc. | Assembly of light emitting diodes for lighting applications |
| US20060229689A1 (en) * | 2005-04-08 | 2006-10-12 | Led Technologies, Llc | LED therapy device |
| WO2007087374A2 (en) | 2006-01-24 | 2007-08-02 | Nomir Medical Technologies, Inc. | Optical method and device for modulation of biochemical processes in adipose tissue |
| US7517101B2 (en) * | 2006-03-28 | 2009-04-14 | Tobin Stephen M | Convertible lamp array |
| GB0700580D0 (en) | 2007-01-11 | 2007-02-21 | Photocure Asa | Use |
| JP3133297U (ja) * | 2007-04-25 | 2007-07-05 | 聰章 張 | 方向自在光線療法用具 |
| GB0724279D0 (en) | 2007-12-12 | 2008-01-23 | Photocure Asa | Use |
| JP2011506425A (ja) | 2007-12-14 | 2011-03-03 | フォトデルマ エスアー | 治療的及び美容的方法に有用な新規化合物 |
| CN101965534A (zh) | 2008-02-28 | 2011-02-02 | 皇家飞利浦电子股份有限公司 | 用于分散来自多个光源的光以消除其间的可见边界的装置、具有这样的装置的光疗设备，以及方法 |
| GB0807850D0 (en) * | 2008-04-30 | 2008-06-04 | Photopharmica Ltd | Treatment device |
| US20100106228A1 (en) | 2008-10-27 | 2010-04-29 | Steven Gardner | Device and method of phototherapy for jaundiced infants |
| GB0823472D0 (en) | 2008-12-23 | 2009-01-28 | Photocure Asa | Product |
| GB0900461D0 (en) * | 2009-01-12 | 2009-02-11 | Photocure Asa | Photodynamic therapy device |
| US8734163B1 (en) * | 2009-04-28 | 2014-05-27 | Musco Corporation | Apparatus, method, and system for on-site evaluation of illumination scheme using a mobile lighting evaluation system |
| US20120296260A1 (en) | 2009-06-09 | 2012-11-22 | Freimut Vizethum | Device and method for photodynamic therapy |
| CN102458388B (zh) | 2009-06-11 | 2016-09-28 | 光治疗Asa公司 | 半固体组合物及药物制品 |
| CN102802612A (zh) | 2009-06-11 | 2012-11-28 | 光治疗Asa公司 | 含有5-氨基酮戊酸的固态组合物 |
| JP2013521251A (ja) | 2010-03-01 | 2013-06-10 | フォトキュア エイエスエイ | 美容組成物 |
| EP2585111A1 (en) | 2010-06-23 | 2013-05-01 | Photocure ASA | Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent |
| BR112013000613A2 (pt) | 2010-07-09 | 2016-06-28 | Photocure Asa | composições secas e dispositivos que contêm tais composições secas |
-
2012
- 2012-10-05 US US13/646,274 patent/US20140067024A1/en not_active Abandoned
-
2013
- 2013-08-30 JP JP2015529032A patent/JP2015528338A/ja active Pending
- 2013-08-30 ES ES13756136.1T patent/ES2685326T3/es active Active
- 2013-08-30 BR BR112015004114A patent/BR112015004114A2/pt not_active IP Right Cessation
- 2013-08-30 WO PCT/EP2013/067982 patent/WO2014033254A1/en not_active Ceased
- 2013-08-30 EA EA201590362A patent/EA201590362A1/ru unknown
- 2013-08-30 CA CA2881614A patent/CA2881614A1/en not_active Abandoned
- 2013-08-30 EP EP13756136.1A patent/EP2890458B1/en not_active Not-in-force
-
2015
- 2015-09-24 US US14/863,987 patent/US9399146B2/en not_active Expired - Fee Related
-
2016
- 2016-09-01 US US15/254,850 patent/US20160367832A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110393862A (zh) * | 2019-08-28 | 2019-11-01 | 武汉优瑞科技有限公司 | 一种用于耳朵治疗的光子治疗仪 |
Also Published As
| Publication number | Publication date |
|---|---|
| US20160008623A1 (en) | 2016-01-14 |
| EP2890458B1 (en) | 2018-05-30 |
| EP2890458A1 (en) | 2015-07-08 |
| JP2015528338A (ja) | 2015-09-28 |
| BR112015004114A2 (pt) | 2017-07-04 |
| WO2014033254A1 (en) | 2014-03-06 |
| EA201590362A1 (ru) | 2015-11-30 |
| US20160367832A1 (en) | 2016-12-22 |
| US9399146B2 (en) | 2016-07-26 |
| US20140067024A1 (en) | 2014-03-06 |
| ES2685326T3 (es) | 2018-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9399146B2 (en) | Methods of treating acne using dual panel photodynamic therapy lamp | |
| US20230321243A1 (en) | Methods for photodynamic therapy | |
| US20250235715A1 (en) | Adjustable illuminator for photodynamic therapy and diagnosis | |
| Sorbellini et al. | Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update | |
| Sakamoto et al. | Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy | |
| Keyal et al. | Photodynamic therapy for the treatment of different severity of acne: A systematic review | |
| Moseley et al. | Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy | |
| Ma et al. | Low-dose topical 5-aminolevulinic acid photodynamic therapy in the treatment of different severity of acne vulgaris | |
| Garcia-Zuazaga et al. | Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer | |
| US20110224598A1 (en) | Radiant near infrared light emitting diode exposure as skin preparation | |
| Tao et al. | Low-dose topical 5-aminolevulinic acid photodynamic therapy in the treatment of different severity of acne vulgaris | |
| JP2024543045A (ja) | 光力学的療法の照明器および方法 | |
| Falkenberg et al. | Pretreatment with ablative fractional carbon dioxide laser improves treatment efficacy in a synergistic PDT protocol for actinic keratoses on the head | |
| Torezan et al. | Photodynamic therapy in dermatology: basic principles | |
| ES2778031T3 (es) | Método para el tratamiento del acné | |
| Garofalo et al. | Combination of laser therapy and photodynamic therapy with 5-aminolevulinic acid patch for the treatment of actinic cheilitis | |
| JP2024527985A (ja) | 設定可能な光線力学的療法システム及び方法 | |
| Kocki et al. | Nurses and pharmacists in interdisciplinary team of health care providers in photodynamic therapy | |
| Savas et al. | Photodynamic therapy | |
| Gu et al. | Light-emitting diodes for healthcare and well-being | |
| Andreev et al. | Photodynamic therapy as an up-to-date medical technology for the treatment of vulgar acne | |
| Nugrahania et al. | The Utilization of Nanoemulsified Aminolevulinic Acid in Photodynamic Therapy for Actinic Keratosis | |
| Golbari et al. | Daylight Photodynamic Therapy for Actinic Keratosis | |
| Gold | Lasers and Light Sources for Medical Dermatologic Conditions | |
| Silva et al. | Design of matrix irradiation system for external tissue phototeraphy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |
Effective date: 20190830 |